225 related articles for article (PubMed ID: 16632213)
21. Cutaneous melanoma in the elderly.
Testori A; Soteldo J; Sances D; Mazzarol G; Trifirò G; Zonta M; Rastrelli M; Schenone F; Verrecchia F
Melanoma Res; 2009 Jun; 19(3):125-34. PubMed ID: 19381113
[TBL] [Abstract][Full Text] [Related]
22. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
Bower M; Scoggins CR
J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
[TBL] [Abstract][Full Text] [Related]
24. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision.
Scolyer RA; Thompson JF; McCarthy SW
Cancer; 2004 Nov; 101(9):2141-2; author reply 2142-3. PubMed ID: 15372477
[No Abstract] [Full Text] [Related]
26. Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
McHugh JB; Su L; Griffith KA; Schwartz JL; Wong SL; Cimmino V; Chang AE; Johnson TM; Sabel MS
Ann Surg Oncol; 2006 Sep; 13(9):1216-23. PubMed ID: 16952026
[TBL] [Abstract][Full Text] [Related]
27. [Feasibility and technical problems of sentinel node analysis in melanoma].
Mebazaa A; Kerob D; Toubert ME; Verola O; Servant JM; Baccard M; Billotey C; Bustamante K; Vandici FO; Basset-Seguin N; Ollivaud L; Morel P; Lebbé C
Ann Chir Plast Esthet; 2007 Feb; 52(1):14-23. PubMed ID: 17141391
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
29. Regressed subungual melanoma simulating cellular blue nevus: managed with sentinel lymph node biopsy.
Yang CH; Yeh JT; Shen SC; Lo YF; Kuo TT; Chang JW
Dermatol Surg; 2006 Apr; 32(4):577-80; discussion 580-1. PubMed ID: 16681670
[TBL] [Abstract][Full Text] [Related]
30. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
Kruit WH;
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
[TBL] [Abstract][Full Text] [Related]
31. [Cutaneous melanoma].
Eigentler TK; Mügge LO; Bembenek A; Garbe C
Hautarzt; 2007 Oct; 58(10):885-97; quiz 898. PubMed ID: 17973138
[TBL] [Abstract][Full Text] [Related]
32. Molecular upstaging of sentinel lymph nodes in melanoma: where are we now?
Martinez SR; Mori T; Hoon DS
Surg Oncol Clin N Am; 2006 Apr; 15(2):331-40. PubMed ID: 16632218
[TBL] [Abstract][Full Text] [Related]
33. Tenascin C: a defensive role in sentinel lymph nodes of melanoma patients?
Gazzaniga P; Cigna E; Vincenzi B; Bottoni U; Vasaturo F; Alfano C; Calvieri S; Frati L; Scuderi N; Aglianò AM; Gradilone A
J Dermatol Sci; 2009 Mar; 53(3):239-41. PubMed ID: 19070467
[No Abstract] [Full Text] [Related]
34. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
[TBL] [Abstract][Full Text] [Related]
35. Progress in melanoma histopathology and diagnosis.
Piris A; Mihm MC
Hematol Oncol Clin North Am; 2009 Jun; 23(3):467-80, viii. PubMed ID: 19464597
[TBL] [Abstract][Full Text] [Related]
36. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
37. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
[TBL] [Abstract][Full Text] [Related]
39. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma].
Avilés-Izquierdo JA; Lázaro-Ochaita P
Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553
[TBL] [Abstract][Full Text] [Related]
40. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Scheri RP; Essner R; Turner RR; Ye X; Morton DL
Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]